This inventor holds 4 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Ucbbiopharma Srl. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Berkshire, GB (2022)
- Victoria, AU (2023)
- Slough, GB (2024)
Company Filing History:
Years Active: 2022-2024
Title: The Innovations of Andrew Jeffrey Yates in Biopharmaceuticals
Introduction
Andrew Jeffrey Yates is an accomplished inventor based in Berkshire, GB, recognized for his significant contributions to the field of biopharmaceuticals. With a total of four patents to his name, Yates has focused on enhancing the efficacy of cell culture methods and pharmaceutical compositions, particularly in the production of recombinant proteins and antibodies.
Latest Patents
One of Yates' latest innovations is a patent focusing on cell culture methods. This invention pertains to the use of limited amounts of cysteine and tryptophan in cell culture mediums during the production of recombinant proteins. Notably, this approach yields antibodies with reduced heterogeneity, specifically minimizing charge variant heterogeneity. Another significant patent involves pharmaceutical compositions that comprise an antibody or a fragment that binds IL-17A and IL-17F, combined with glycine, acetate buffer at pH 4.6 to 5.5, and polysorbate 80. These innovations have the potential to improve therapeutic applications significantly.
Career Highlights
Yates is currently employed at UCB Biopharma Srl, a leading company in the biopharmaceutical industry. His work focuses on developing more effective therapies through innovative cellular production techniques and compositions. Yates' research is aimed at addressing critical challenges in the formulation and production of biopharmaceutical products.
Collaborations
Throughout his career, Andrew has collaborated with notable colleagues, including Sandrine Durran and Jan Ivo Massant. These partnerships have fostered a creative and productive environment, leading to advancements in the development of biopharmaceutical technologies.
Conclusion
Andrew Jeffrey Yates exemplifies the innovative spirit of modern inventors in the biopharmaceutical field. With his patented inventions and collaborative efforts, he continues to push the boundaries of science and medicine, paving the way for future advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile